크리티컬 케어 기기 시장 - 제품별, 용도 분야별, 최종 용도별 및 예측(2023-2032년)

Global Critical Care Devices Market is poised to accrue remarkable gains through 2032, credited to the growing demand for ventilators for disease management. Moreover, the increasing incidence of chronic respiratory disorders and the associated comorbidities has propelled the demand for ventilators. As per the NCD Alliance, an estimated 550 million people globally are diagnosed with chronic respiratory diseases.

Moreover, the growing emphasis of industry players on R&D activities for developing ventilators in therapeutic space is also working in favor of industry expansion. In fact, in January 2023, Getinge AB, a Swedish medical technology company, announced the launch of its new Servo-c mechanical ventilator, providing lung-protective therapeutic tools for the expansion of its ICU offerings.

Overall, the critical care devices market is segmented based on product, application, end-use, and region.

On the basis of product, the critical care devices industry from the ECG devices segment is expected to register significant gains through 2032, owing to ongoing product innovations in the field. For instance, in January 2022, Royal Philips, a global health technology provider, announced the launch of the first-ever at-home full-service 12-lead electrocardiogram (ECG) solution. It is a clinical-grade patient-focused ECG solution that pairs data readings comparable to clinical ECGs to bring innovation across the care continuum.

In terms of application, the critical care devices market share from the neurology segment is poised to grow at over 6% CAGR from 2023 to 2032. The growing occurrence of neurological diseases such as Alzheimer's disease, multiple sclerosis (MS), traumatic brain injury, epilepsy, and others has proliferated the need for critical care devices. As per the WHO, epilepsy affects around 5 million people globally every year. Moreover, recent advancements in neurological devices will further create a strong impetus for segment expansion.

With respect to end-use, the critical care devices market size from the ambulatory surgical centers segment is anticipated to grow at a substantial CAGR from 2023 to 2032. The high availability of technologically advanced critical care devices and less cost of treatment has increased patient footfall in ambulatory surgical centers. Additionally, shorter hospital stays and low risk of hospital-acquired infections have made them the preferred healthcare provider for the treatment of severe diseases.

Regionally speaking, the Asia Pacific critical care devices market is slated to record a valuation of over USD 25 billion by 2032. The rising prevalence of severe illnesses such as cardiovascular disorders, cancer, and others has bolstered the demand for critical care devices in the region. As per the Journal of Thoracic Oncology, lung cancer makes up 8.1% of all cancer-related deaths in India. Regional growth can also be ascribed to the robust presence of prominent industry players such as Mindray, Asahi Kasei Corporation, and others who are consistently engaged in product innovations.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Critical care devices industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends (USD Million & 000' Units)
  • 2.1.2 Product trends (USD Million & 000' Units)
  • 2.1.3 Application field trends (USD Million & 000' Units)
  • 2.1.4 End-use trends (USD Million & 000' Units)
  • 2.1.5 Regional trends (USD Million & 000' Units)

Chapter 3 Critical Care Devices Industry Insights

• 3.1 Industry landscape, 2018-2032
• 3.2 Industry ecosystem analysis
  • 3.2.1 Vendor matrix
  • 3.2.2 Distribution channel analysis
  • 3.2.3 Profit margin trends
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Rising demand for intensive care units
    • 3.3.1.2 Growing incidence of chronic diseases throughout the globe
    • 3.3.1.3 Technological advancements in critical care
    • 3.3.1.4 Surging demand for ventilators for better management of diseases
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Lack of skilled professionals
    • 3.3.2.2 High cost of critical care devices
• 3.4 Growth potential analysis
  • 3.4.1 By product
  • 3.4.2 By application field
  • 3.4.3 By end-use
• 3.5 COVID- 19 impact analysis
  • 3.5.1 Impact of COVID-19 on 10 major markets
    • 3.5.1.1 Overview
    • 3.5.1.2 U.S.
    • 3.5.1.3 Germany
    • 3.5.1.4 UK
    • 3.5.1.5 France
    • 3.5.1.6 Spain
    • 3.5.1.7 Italy
    • 3.5.1.8 China
    • 3.5.1.9 India
    • 3.5.1.10 Australia
    • 3.5.1.11 Brazil
  • 3.5.2 Impact of COVID-19 on industry segments, by major markets (2020)
    • 3.5.2.1 Infusion pumps
    • 3.5.2.2 Ventilators
    • 3.5.2.3 ECG devices
    • 3.5.2.4 Multiparameter monitoring devices
    • 3.5.2.5 CRRT machines
    • 3.5.2.6 Hemodialysis machines
    • 3.5.2.7 Feeding tubes
  • 3.5.3 Impact of COVID-19 on industry value chain
    • 3.5.3.1 Research & development
    • 3.5.3.2 Manufacturing
    • 3.5.3.3 Marketing
    • 3.5.3.4 Supply
  • 3.5.4 Impact of COVID-19 on industry competition
    • 3.5.4.1 Strategy
    • 3.5.4.2 Product portfolio
    • 3.5.4.3 Business growth
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Europe
  • 3.6.3 Asia Pacific
• 3.7 Technology landscape
• 3.8 Ventilator - vendor matrix analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape

• 4.1 Introduction
  • 4.1.1 GE Healthcare
  • 4.1.2 Koninklijke Philips N.V.
  • 4.1.3 Medtronic, Inc.
  • 4.1.4 Boston Scientific Corporation
• 4.2 Competitive dashboard, 2022
• 4.3 Company matrix analysis, 2022
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategic outlook matrix

Chapter 5 Critical Care Devices Market, By Product

• 5.1 Key segment trends
• 5.2 Defibrillators
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 5.3 Multiparameter monitoring devices
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 5.4 ECG devices
  • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 5.5 Hemodialysis machines
  • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.5.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 5.6 Infusion pumps
  • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.6.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 5.7 Ventilators
  • 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.7.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 5.8 Feeding tubes
  • 5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.8.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 5.9 Anesthesia monitors
  • 5.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.9.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 5.10 CRRT machines
  • 5.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.10.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 5.11 Others
  • 5.11.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.11.2 Market estimates and forecast, 2018 - 2032 (000' Units)

Chapter 6 Critical Care Devices Market, By Application Field

• 6.1 Key segment trends
• 6.2 Renal Care
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.2.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 6.3 Cardiology
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 6.4 Neurology
  • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 6.5 Others
  • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5.2 Market estimates and forecast, 2018 - 2032 (000' Units)

Chapter 7 Critical Care Devices Market, By End-use

• 7.1 Key end-use trends
• 7.2 Hospitals
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.2.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 7.3 Ambulatory surgical centers
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 7.4 Specialty clinics
  • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.4.2 Market estimates and forecast, 2018 - 2032 (000' Units)
• 7.5 Others
  • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.5.2 Market estimates and forecast, 2018 - 2032 (000' Units)

Chapter 8 Critical Care Devices Market, By Region

• 8.1 Key regional trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Poland
  • 8.3.7 Austria
  • 8.3.8 Denmark
  • 8.3.9 Switzerland
  • 8.3.10 The Netherlands
  • 8.3.11 Czech Republic
  • 8.3.12 Sweden
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Thailand
  • 8.4.7 Indonesia
  • 8.4.8 Vietnam
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Colombia
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Iran

Chapter 9 Company Profiles

• 9.1 Koninklijke Philips N.V.
• 9.2 ResMed
• 9.3 Dragerwerk AG & Co. KGaA
• 9.4 GE Healthcare
• 9.5 Medtronic
• 9.6 ICU Medical, Inc.
• 9.7 Fresenius Medical Care
• 9.8 Smiths Medical
• 9.9 Biometrix
• 9.10 Airon Corporation
• 9.11 OSI Systems
• 9.12 Avanos Medical
• 9.13 Skanray Technologies Pvt. Ltd
• 9.14 Becton Dickinson and Company (BD)
• 9.15 Boston Scientific corporation
• 9.16 Getinge AB
• 9.17 Hamilton Medical
• 9.18 VYAIRE
• 9.19 Q-core Medical
• 9.20 Ventec Life Systems
• 9.21 Bunnell Incorporated
• 9.22 Teleflex Incorporated
• 9.23 Asahi Kasei Corporation
• 9.24 Air Liquide Medical Systems India
• 9.25 Breas Medical
• 9.26 Cardinal Health
• 9.27 Baxter
• 9.28 B. Braun Melsungen AG